Ritivel
AI-native workspace for regulatory and medical writing teams at life-sciences companies.
Executive Summary
Ritivel is an AI-native regulatory platform designed for life-sciences companies, including pharmaceutical, biotechnology, and medical device firms. It provides an intelligent workspace for regulatory and medical writing teams, significantly accelerating the drafting of critical documents such as CTDs, CSRs, INDs, and BLAs from weeks to minutes. The platform also offers a powerful search and interpretation tool for the latest FDA, EMA, and ICH regulations, providing instant and up-to-date answers specific to a drug or medical device. This enables teams to ensure compliance and streamline their writing processes efficiently.
Use Cases
- Drafting regulatory documents (CTDs, CSRs, INDs, BLAs)
- Interpreting FDA, EMA, and ICH regulations
- Accelerating medical writing workflows
- Ensuring regulatory compliance in document creation
Features
Intelligence
- AI-Native Regulatory Platform: Leverages AI to streamline regulatory and medical writing processes.
- Instant Regulatory Answers: Provides immediate and up-to-date interpretations of FDA, EMA, and ICH regulations.
Pricing
- Starting Price
- Contact sales
- Target Customer
- Pharmaceutical,Biotechnology,Medical Device
Ratings & Reviews
G2: N/A/5
About Ritivel
Ritivel is an AI-native workspace designed for regulatory and medical writing teams in the life sciences sector. The company provides regulatory platforms that leverage AI agents to draft complex documents like CTDs, CSRs, INDs, and BLAs in minutes, significantly accelerating FDA submissions.